Results 151 to 160 of about 55,323 (311)
Measurement of Plasma Apolipoprotein A-I and B in Hyperlipidemic Subjects
Shunichi KOGA+2 more
openalex +2 more sources
Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11. [PDF]
Peter Cheung+5 more
openalex +1 more source
The utility of molecularly imprinted polymers for mass spectrometric protein and proteomics analysis
Abstract Selective and efficient sample clean‐up is important in mass spectrometric protein‐ and proteomics analyses from biological matrices. Molecularly imprinted polymers (MIPs), polymers prepared to have tailor‐made cavities for capture of target analytes may by such represent an interesting alternative for selective clean‐up.
Trine Grønhaug Halvorsen+1 more
wiley +1 more source
Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia. [PDF]
Philippa J. Talmud+5 more
openalex +1 more source
Identification of circulating apolipoproteins synthesized by rat small intestine in vivo.
A.L. Wu, H.G. Windmueller
openalex +1 more source
Exploring biomarkers of neurodegeneration in epilepsy: Critical insights
Abstract The advent of biofluid biomarkers for neurodegenerative disorders has precipitated a surge in recent evidence regarding their role in epilepsy. In this literature review, we examine the diagnostic, prognostic, and therapeutic potential of several biomarkers, including amyloid‐beta (Aβ) protein, total (t‐tau), phosphorylated tau (p‐tau) protein,
Rida Farhan+7 more
wiley +1 more source
Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells
Two APOL1 gene variants, which likely evolved to protect individuals from African sleeping sickness, are strongly associated with nondiabetic kidney disease in individuals with recent African ancestry. Consistent with its role in trypanosome killing, the
Dongmei Cheng+8 more
doaj
Tau‐targeting nanoparticles for treatment of Alzheimer's disease
Through review of comprehensive literature and research studies, it is found that tau‐targeting nanoparticles may posit beneficial applications to AD therapy. By targeting a key molecular mechanism known to propagate AD pathogenesis, tau‐targeting nanoparticles have the potential to facilitate tau tangle clearance, promote synaptic integrity, and ...
Shreya Pawar+3 more
wiley +1 more source